COX-2 activity transiently contributes to increased water and NaCl excretion in the polyuric phase after release of ureteral obstruction.
about
Physiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidneyA novel therapeutic effect of statins on nephrogenic diabetes insipidusNonsteroidal Anti-Inflammatory Drugs and the KidneyAngiotensin II regulates V2 receptor and pAQP2 during ureteral obstructionPotential involvement of P2Y2 receptor in diuresis of postobstructive uropathy in rats.Urinary tract obstruction induces transient accumulation of COX-2-derived prostanoids in kidney tissueAquaporin-2 regulation in health and disease.Bilateral ureteral obstruction induces early downregulation and redistribution of AQP2 and phosphorylated AQP2.NSAIDs Alter Phosphorylated Forms of AQP2 in the Inner Medullary Tip.N-acetylcysteine protects against renal injury following bilateral ureteral obstruction.Lithium induces microcysts and polyuria in adolescent rat kidney independent of cyclooxygenase-2.Plant ureases and related peptides: understanding their entomotoxic properties.Postobstructive diuresis in cats with naturally occurring lower urinary tract obstruction: incidence, severity and association with laboratory parameters on admission.Cyclooxygenase 2 inhibition exacerbates AQP2 and pAQP2 downregulation independently of V2 receptor abundance in the postobstructed kidney.Expression of renal aquaporins is down-regulated in children with congenital hydronephrosis.Inhibition of mitochondrial complex-1 restores the downregulation of aquaporins in obstructive nephropathy.Role of mitochondrial oxidative stress in modulating the expressions of aquaporins in obstructive kidney disease.
P2860
Q26771378-7169F706-13BD-48E7-BC3D-9FFD9336CCA7Q27005638-A14316E7-2FCF-4F16-B40A-BF6D9903CEB9Q28386844-4F39F038-844F-4F70-9E2C-EC93460F4208Q28580496-BCA565FA-E145-4E35-9FC5-FA7BA6B6632AQ33727799-DED453D9-19DB-4C12-8282-FD4577D6FD17Q33784332-5D86A76A-E2CA-4511-9523-D0262507E73EQ34310224-4EF536DD-59BA-496D-A134-7909F0BD70A2Q35086975-4A3F2691-3D2F-43C8-95C2-95C0E55FE500Q35827119-BB696F27-6BA9-43E9-9A33-810A7D6E650EQ36889883-EEDBD2EF-5E67-41FF-94D1-9C30F31E3BE0Q37668476-D2267D84-C9E8-44D1-9348-788FEFB463A3Q37999791-2E9CF409-AC37-44CD-A9F3-77AD6677226FQ39186290-94D10ECE-3AA3-4144-8A66-410F072664CAQ43182529-0A89A986-CAB5-4833-BE6A-0A54F281DC77Q48067930-14874699-FDAB-4745-AC11-A26473CC0FB8Q51642781-253C3E02-59FA-473B-8BEE-4BB51AC63358Q51759676-E2952C25-AF93-4444-A7D0-6C08D5770396
P2860
COX-2 activity transiently contributes to increased water and NaCl excretion in the polyuric phase after release of ureteral obstruction.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
COX-2 activity transiently con ...... lease of ureteral obstruction.
@en
COX-2 activity transiently con ...... lease of ureteral obstruction.
@nl
type
label
COX-2 activity transiently con ...... lease of ureteral obstruction.
@en
COX-2 activity transiently con ...... lease of ureteral obstruction.
@nl
prefLabel
COX-2 activity transiently con ...... lease of ureteral obstruction.
@en
COX-2 activity transiently con ...... lease of ureteral obstruction.
@nl
P2093
P2860
P1476
COX-2 activity transiently con ...... elease of ureteral obstruction
@en
P2093
Boye L Jensen
Horst Schweer
Jørgen Frøkiaer
Maria Diget
Mark A Knepper
Sukru Oguzkan Topcu
Søren Nielsen
P2860
P304
P356
10.1152/AJPRENAL.00394.2006
P577
2007-01-16T00:00:00Z